Sight Sciences, Inc.

NASDAQ:SGHT

3.57 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 20.15721.3719.26518.75120.00923.47118.82420.54318.67717.22914.88114.68513.10112.5358.6358.9918.6513.5026.496
Cost of Revenue 3.253.0252.7932.7762.6773.3813.0483.6652.9282.7363.0331.9422.0622.3052.3012.3762.622.0852.128
Gross Profit 16.90718.34516.47215.97517.33220.0915.77616.87815.74914.49311.84812.74311.03910.236.3346.6156.0311.4174.368
Gross Profit Ratio 0.8390.8580.8550.8520.8660.8560.8380.8220.8430.8410.7960.8680.8430.8160.7340.7360.6970.4050.672
Reseach & Development Expenses 4.7464.3164.6363.4274.2395.2214.6695.2336.0535.9265.6464.3694.2793.5463.442.8732.1581.4432.4
General & Administrative Expenses 00021.55800026.09800020.9900011.375000
Selling & Marketing Expenses 0002.10002.60002.10000.8000
SG&A 23.3926.6826.55923.65826.50430.05628.67528.69831.54131.43128.39523.0920.7917.7614.5512.17511.2287.66410.678
Other Expenses 0-0.044-0.0081.781.8861.791.7911.3790.7660.095-0.015-0.044-2.001-5.4350.5520.108-0.197-0.0730.091
Operating Expenses 28.13630.99631.19527.08530.74335.27733.34433.93137.59437.35734.04127.45925.06921.30617.9915.04813.3869.10713.078
Operating Income -11.229-12.651-14.723-11.11-13.411-15.187-17.568-17.053-21.845-22.864-22.193-14.716-14.03-11.076-11.656-8.433-7.355-7.69-8.71
Operating Income Ratio -0.557-0.592-0.764-0.593-0.67-0.647-0.933-0.83-1.17-1.327-1.491-1.002-1.071-0.884-1.35-0.938-0.85-2.196-1.341
Total Other Income Expenses Net 0.3290.337-1.5260.4290.4540.4410.5150.156-0.365-0.97-1.061-1.122-3.123-6.517-0.532-0.656-0.734-0.62-0.434
Income Before Tax -10.9-12.314-16.249-10.681-12.957-14.746-17.053-16.897-22.21-23.834-23.254-15.838-17.153-17.593-12.188-9.089-8.089-8.31-9.144
Income Before Tax Ratio -0.541-0.576-0.843-0.57-0.648-0.628-0.906-0.823-1.189-1.383-1.563-1.079-1.309-1.404-1.411-1.011-0.935-2.373-1.408
Income Tax Expense 0.1660.0150.0170.010.0780.0080.0140.010.0190.0090.0090.0980.0160.0220.0520.0160.0080.0060.031
Net Income -11.066-12.329-16.266-10.691-13.035-14.754-17.067-16.907-22.229-23.843-23.263-15.936-17.169-17.615-12.24-9.105-8.097-8.316-9.175
Net Income Ratio -0.549-0.577-0.844-0.57-0.651-0.629-0.907-0.823-1.19-1.384-1.563-1.085-1.311-1.405-1.417-1.013-0.936-2.375-1.412
EPS -0.22-0.25-0.33-0.22-0.27-0.3-0.35-0.35-0.46-0.5-0.49-0.34-0.43-0.42-0.29-0.26-0.23-0.24-0.26
EPS Diluted -0.22-0.25-0.33-0.22-0.27-0.3-0.35-0.35-0.46-0.5-0.49-0.34-0.43-0.42-0.29-0.26-0.23-0.24-0.26
EBITDA -9.591-11.069-14.853-9.14-11.365-13.001-15.389-15.353-20.769-22.573-22.029-14.464-15.725-16.157-10.813-8.325-7.007-7.545-8.567
EBITDA Ratio -0.476-0.587-0.754-0.582-0.576-0.571-0.838-0.763-1.119-1.31-1.48-1.005-1.177-1.305-1.27-0.926-0.81-2.175-1.301